文档介绍：A Brief Overview of This Month’s JACI
Volume 135, Number 2, February 2015
REVIEWS AND FEATURE ARTICLES 395 D prostanoid receptor 2 (chemoattractant
receptor–homologous molecule expressed
299 Asthma phenotypes and the use of biologic
on T 2 cells) protein expression in asthmatic
medications in asthma and allergic disease: H
patients and its effects on bronchial epithelial
The next steps toward personalized care
cells
Merritt L. Fajt et al
Sally E. Stinson et al
312 The future of biologics: Applications
407 The Xolair Pregnancy Registry (EXPECT): The
for food allergy
safety of omalizumab use during pregnancy
a N. Bauer et al
Jennifer Namazy et al
324 The translational revolution and use
413 Subsets of airway myeloid-derived regulatory
of biologics in patients with inflammatory
cells distinguish mild asthma from chronic
skin diseases obstructive pulmonary disease
Shinji Noda et al
Jessy S. Deshane et al
337 The potential pharmacologic mechanisms
425 DNA-dependent protein kinase inhibition
of omalizumab in patients with chronic
blocks asthma in mice and modulates
spontaneous urticaria +
human endothelial and CD4 T-cell function
Tse Wen Chang et al without causing bined
343 Worms as therapeutic agents for allergy immunodeficiency
and asthma: Understanding why benefits Mohamed A. Ghonim et al
in animal studies have not transl